Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?

Minimal residual disease (MRD) assessment plays a central role in risk stratification and treatment guidance in paediatric patients with acute lymphoblastic leukaemia (ALL). As such, MRD prior to haematopoietic stem cell transplantation (HSCT) is a major factor that is independently correlated with...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Pietro Merli, Marianne Ifversen, Tony H. Truong, Hanne V. Marquart, Jochen Buechner, Matthias Wölfl, Peter Bader
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2021-11-01
Schriftenreihe:	Frontiers in Pediatrics
Schlagworte:	minimal residual disease (MRD) acute lymphoblastic leukaemia (ALL) haematopoietic stem cell transplantation (HSCT) children relapse
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fped.2021.777108/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!